Author:
Pal Sumanta K.,Sonpavde Guru,Agarwal Neeraj,Vogelzang Nicholas J.,Srinivas Sandy,Haas Naomi B.,Signoretti Sabina,McGregor Bradley A.,Jones Jeremy,Lanman Richard B.,Banks Kimberly C.,Choueiri Toni K.
Reference29 articles.
1. Metastatic renal cell carcinoma: contending with a sea change in therapy;Pal;Urol Oncol,2015
2. Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial;Motzer;Lancet Oncol,2015
3. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial;Sternberg;J Clin Oncol,2010
4. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma;Hudes;N Engl J Med,2007
5. Pazopanib versus sunitinib in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2013
Cited by
110 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献